CAMP
Camp4 Therapeutics Corp
Latest Form 4:Sale$1.6MbySchwab Andrew J. (Director) · filed Aug 31, 2026
Camp4 Therapeutics Corp (CAMP) has 16 SEC Form 4 filings (20 transaction rows) in the rolling window, disclosed by 9 distinct insiders. Most recent filing: Aug 31, 2026.
The most active filer is Director Schwab Andrew J. with 5 filings. Insiders have net sold $2.4M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Joshua Mandel-Brehm
- Employees:48
- HQ:Cambridge, MA, US
- IPO:2024-10-11
Insider Buying
$8.6M
reported purchases (SEC code P)
Insider Selling
$2.5M
reported sales (SEC code S)
Unique Insiders
9
in the rolling window
Market Cap
$205.6M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Director | Sale | 400,000 | $1.6M | Aug 31 | SEC ↗ | |
| Director | Sale | 10 | $45 | Aug 26 | SEC ↗ | |
| Director | Sale | 45,147 | $215K | Aug 21 | SEC ↗ | |
| Director | Sale | 114,700 | $521K | Aug 21 | SEC ↗ | |
| Director | Sale | 32,018 | $144K | Aug 21 | SEC ↗ | |
Tardiff DanielFirst filing | Chief Scientific Officer | Sale | 1,738 | $8K | Aug 20 | SEC ↗ |
Gold KellyFirst in 11 months | Chief Financial Officer | Purchase | 6,551 | $11K | Aug 5 | SEC ↗ |
Young Richard AFirst in 11 months | Director | Purchase | 16,378 | $27K | Aug 5 | SEC ↗ |
Maricich YuriFirst in 11 months | Chief Medical Officer | Purchase | 6,551 | $11K | Aug 5 | SEC ↗ |
Mandel-Brehm JoshFirst in 11 months | Chief Executive Officer | Purchase | 6,551 | $11K | Aug 5 | SEC ↗ |
5AM Partners VI, LLCFirst filing | 10% Owner | Purchase | 2,941,176 | $4.5M | Sep 15 | SEC ↗ |
Mandel-Brehm JoshFirst filing | Chief Executive Officer | Purchase | 6,060 | $10K | Sep 11 | SEC ↗ |
Nashat AmirFirst filing | Director, 10% Owner | Purchase | 1,307,189 | $2.0M | Sep 11 | SEC ↗ |
Maricich YuriFirst filing | Chief Medical Officer | Purchase | 6,060 | $10K | Sep 11 | SEC ↗ |
Young Richard AFirst filing | Director | Purchase | 15,151 | $25K | Sep 11 | SEC ↗ |
Gold KellyFirst filing | Chief Financial Officer | Purchase | 6,060 | $10K | Sep 11 | SEC ↗ |
Polaris Management Co. VII, L.L.C.First filing | 10% Owner | Purchase | 1,307,189 | $2.0M | Sep 11 | SEC ↗ |
Related companies
Camp4 Therapeutics Corp is in the Healthcare sector.